We assessed the longitudinal effects of ECT on levels of peripheral inflammation (CRP, IL-6 and TNF-α) in subjects with TRD, in comparison to HC subjects, and in association with post-treatment clinical outcomes. The gene discussed is CRP; the disease is treatment resistant depression.